Publications by authors named "Yuta Hoshi"

Claim this Profile
I
Intracranial antitumor efficacy of combination treatment with encorafenib plus binimetinib in BRAF V600E-mutated anaplastic thyroid carcinoma.
Ryutaro Onaga, Tomohiro Enokida, Toshifumi Tomioka, Shingo Sakashita, Masanobu Sato, Yuta Hoshi

Auris Nasus Larynx· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LH-RH agonist monotherapy for androgen receptor-positive recurrent and/or metastatic salivary gland cancer: a retrospective study.
Takuma Kishida, Tomohiro Enokida, Ryutaro Onaga, Nobukazu Tanaka, Yuta Hoshi

Int J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan.
Ryutaro Onaga, Tomohiro Enokida, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida

Thyroid· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer.
Ryutaro Onaga, Tomohiro Enokida, Shingo Sakashita, Nobukazu Tanaka, Yuta Hoshi

Int J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of imaging-detected extranodal extension in locally advanced squamous cell carcinoma of the head and neck treated with induction chemotherapy followed by chemoradiotherapy.
Ryutaro Onaga, Tomohiro Enokida, Hirofumi Kuno, Takashi Hiyama, Susumu Okano, Yuta Hoshi

Oral Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE).
Nobukazu Tanaka, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Hideki Tanaka, Yuta Hoshi

Oral Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer.
Ryutaro Onaga, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Yuta Hoshi

Int J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma.
Yuta Hoshi, Tomohiro Enokida, Shingo Tamura, Torahiko Nakashima, Susumu Okano

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.
Takashi Hirai, Yujiro Naito, Shohei Koyama, Yoshimitsu Nakanishi, Kentaro Masuhiro, Yuta Hoshi

JCI Insight· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
Naohiro Takeshita, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Akihisa Wada, Yuta Hoshi

Oral Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck.
Hideki Tanaka, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Yuta Hoshi

Front Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab.
Yuta Hoshi, Satoshi Shirakura, Masato Yamada, Tomonori Sugiyama, Nobuaki Koide

Int J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin.
Ryutaro Onaga, Tomohiro Enokida, Kazue Ito, Yuri Ueda, Susumu Okano, Yuta Hoshi

Front Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory mechanics and cerebral blood flow during heat-induced hyperventilation and its voluntary suppression in passively heated humans.
Bun Tsuji, Yuta Hoshi, Yasushi Honda, Naoto Fujii, Yosuke Sasaki

Physiol Rep· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential role of regulator of G-protein signaling 16 in cell motility mediated by δEF1 family proteins.
Yuta Hoshi, Kaori Endo, Takuya Shirakihara, Akihiko Fukagawa, Keiji Miyazawa

FEBS Lett· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis